Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS Genovese, M. C., Fay, J., Parrino, J., Beyer, D., Iglesias-Rodriguez, M., Graham, N., Boddy, A., Martincova, R., Burmester, G. R. OXFORD UNIV PRESS. 2017: 139
View details for Web of Science ID 000408202100360